Volcano Corp (NASDAQ:VOLC)

CAPS Rating: 2 out of 5

The Company is engages in the development, manufacture and commercialization of intravascular ultrasound and functional measurement products that are used for the diagnosis and treatment of vascular and structural heart disease.

Recs

0
Player Avatar blocksofstock (< 20) Submitted: 6/9/2010 12:51:40 PM : Outperform Start Price: $21.78 VOLC Score: +9.24

Great pipeline of products.

Featured Broker Partners


Advertisement